Health News Articles

Excerpts of key news articles on

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: Explore our full index to revealing excerpts of key major media news articles on dozens of engaging topics. And read excerpts from 20 of the most revealing news articles ever published.

All covid-19 vaccines currently in use in the US are available under emergency access only. None of the covid-19 vaccines in use are actually "approved." Through an emergency access mechanism known as Emergency Use Authorisation (EUA), the products being rolled out still technically remain "investigational." Factsheets distributed to vaccinees are clear: "There is no FDA approved vaccine to prevent covid-19." One key difference between EUA and approval (also called "licensure," and which for vaccines is known as a BLA (Biologics License Application)) was the expected length of follow-up of trial participants. Unlike its clear articulation of two months for an EUA, the FDA has not committed to a clear minimum for approval. Among the six "first in disease" vaccines approved by the FDA since 2006, pre-licensure pivotal trials were a median of 23 months in duration. Duration of protection is not the only question that longer, placebo controlled trials can address. They also address vaccine safety. The BMJ asked Moderna, Pfizer, and Janssen (Johnson and Johnson) what proportion of trial participants were now formally unblinded, and how many originally allocated to placebo have now received a vaccine. Pfizer declined to say, but Moderna announced that "as of April 13, all placebo participants have been offered the Moderna covid-19 vaccine and 98% of those have received the vaccine." In other words, the trial is unblinded, and the placebo group no longer exists.

Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.

I am a 13-year-old in seventh grade, and this is what the pandemic has felt like for me. I consider myself one of the lucky ones. I still got to go to school. Still, it felt like nobody was really there. Usually we sat in a dark room with the lights off and the blinds closed, all of us facing some sort of electronic device, procrastinating and not getting our work done. There are no sports teams. No music rehearsals. No drama club. When I'd get home, the first thing I wanted to do is lay down on my bed and just look up at the ceiling. Every single day. I keep saying to myself, "It's OK because next week will be better." But the next week was always the same. Occasionally, I would break down in tears and have to go to the school counsellor. Some of my classmates have done the same. We don't really need to talk to the counsellor, anyway. What we need is to hang out with our friends. The adults don't really understand. Whenever we'd talk, a teacher would tell us we were spreading spit particles across the room, and that could get someone sick. If we stood up, because we've been sitting for five hours straight, a teacher would tell us to sit back down because we weren't socially distancing. We have been told countless times that if we don't socially distance ... and stop doing the things that make us kids, that make us human beings, we will cause harm to others. Now, kids are scared. If they break these rules they feel like murderers, ungrateful people. But while following these rules we are killing ourselves.

Note: Children's hospitals have reported a sharp uptick in mental illness since the pandemic began. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

After 14 years of legal battles, a federal court ordered the Environmental Protection Agency to take actions that will likely force the neurotoxic pesticide chlorpyrifos off the market. The federal agency has for years been considering mounting evidence that links the pesticide to brain damage in children – including loss of IQ, learning difficulties, ADHD, and autism – but, as the court acknowledged, has repeatedly delayed taking action. "Rather than ban the pesticide or reduce the tolerances to levels that the EPA could find were reasonably certain to cause no harm, the EPA sought to evade through delay tactics its plain statutory duty," Judge Jed S. Rakoff wrote in his decision. "During that time, the EPA's egregious delay exposed a generation of American children to unsafe levels of chlorpyrifos," he wrote, and ordered the EPA to issue a final regulation within 60 days. More than 5 million pounds of chlorpyrifos were applied to crops in 2017, according to the most recent data. The EPA was poised to ban chlorpyrifos in 2016, but the Trump EPA changed course. The reversal, made under EPA Administrator Scott Pruitt, has been tied to a $1 million contribution to President Donald Trump's inaugural fund from Dow Chemical Company, now known as Corteva, which was the primary producer of chlorpyrifos. Patti Goldman, an attorney at Earthjustice who has been overseeing the chlorpyrifos litigation since 2014, said the disparity between the science and the EPA's refusal to act reached new heights during the Trump years.

Note: For more along these lines, see concise summaries of deeply revealing news articles on government corruption and health from reliable major media sources.

Asked about the future of Parkinson's disease in the US, Dr Ray Dorsey says, "We're on the tip of a very, very large iceberg." Dorsey, a neurologist ... believes a Parkinson's epidemic is on the horizon. Parkinson's is already the fastest-growing neurological disorder in the world; in the US, the number of people with Parkinson's has increased 35% the last 10 years, says Dorsey, and "We think over the next 25 years it will double again." Researchers increasingly believe that one factor is environmental exposure to trichloroethylene (TCE), a chemical compound used in industrial degreasing, dry-cleaning and household products such as some shoe polishes and carpet cleaners. To date, the clearest evidence around the risk of TCE to human health is derived from workers who are exposed to the chemical in the work-place. A 2008 peer-reviewed study in the Annals of Neurology, for example, found that TCE is "a risk factor for parkinsonism." And a 2011 study echoed those results, finding "a six-fold increase in the risk of developing Parkinson's in individuals exposed in the workplace to trichloroethylene (TCE)." While some countries heavily regulate TCE (its use is banned in the EU without special authorization) the EPA estimates that 250m lb of the chemical are still used annually in the US. TCE is currently estimated to be present in about 30% of US groundwater. Using activated carbon filtration devices (like Brita filters) can help reduce TCE in drinking water.

Note: For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.

In the summer of 1981, when he was 13, Grant crashed a trail motorbike. Grant hadn't given this childhood memory much thought in the intervening years, but one hot August day ... he suddenly understood it as a clue to his dangerously unhealthy relationship with alcohol. The day before, a team of specialists at the Royal Devon and Exeter hospital had given him an intravenous infusion of ketamine, a dissociative hallucinogen, in common use as an anaesthetic since the 1970s, and more recently one of a group of psychedelic drugs being hailed as a silver bullet in the fight to save our ailing mental health. To date, more than 100 patients with conditions as diverse as depression, PTSD and addiction have been treated in research settings across the UK, using a radical new intervention that combines psychedelic drugs with talking therapy. What was once a fringe research interest has become the foundation of a new kind of healthcare, one that, for the first time in modern psychiatric history, purports to not only treat but actually cure mental ill health. Under its influence, Grant had an out-of-body experience he struggles to put into words. "It was like I was sinking deeper and deeper into myself," he says. "Then I became white… and I left my body. I was up on the ceiling, looking at myself, but I was just this white entity. I felt very serene and humbled; I finally understood my place in the universe, just a white speck of light, I wasn't the centre of everything and that was fine."

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind altering drugs from reliable major media sources.

Massachusetts General Hospital wouldn't seem like a natural fit for a center devoted to mind-altering drugs. But this week, MGH launched the Center for the Neuroscience of Psychedelics to study the potential of psilocybin and other psychoactive drugs to treat conditions such as depression, addiction, trauma, and more. The new center at MGH signifies that the field of psychedelic therapy has arrived. Inspiration came from the search for ways to ease the misery of patients whose mental illness is resistant to traditional treatments. Psychedelics are known to facilitate "plasticity" in the brain, increasing its capacity for change, and [director Jerrold] Rosenbaum said his team wanted to understand how these agents "move the brain to change in a way that can address many of the most anguishing forms of human suffering." The MGH center combines the disciplines of psychiatry, brain imaging, genomic medicine, and chemical biology. Some of the initial work involving patients will use psilocybin and be directed at rumination – the stuck, repetitive thought patterns that underlie several conditions, from addiction to obsessive-compulsive disorder. The future of the center's research is boundless, since psychedelics' role in neuroplasticity and neuritogenesis – the ability to build new synapses – may be useful in palliative care with terminally ill patients as well as in combatting neurodegenerative diseases such as Parkinson's and Alzheimer's.

Note: This article is also available on this webpage. For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.

The new coronavirus variants have raised concerns about whether vaccines will remain effective against this disease. But the vaccines themselves could drive the evolution of more mutants. The virus is always mutating. And if one happens to produce a mutation that makes it less vulnerable to the vaccine, that virus could simply multiply in a vaccinated individual. But even if that happens, that's only one step in the process. If the vaccine keeps virus levels low, even mutated viruses, the infected person won't produce enough to spread to other people. Unfortunately, at the moment, scientists can't answer the most basic questions about this process. How much does the virus actually replicate inside a person who has been vaccinated with either one dose or two? And how effective is that vaccine at limiting infection enough so that the virus levels stay low and prevent the spread to other people? Andrew Read at Penn State University says, whatever the answers may be, vaccine resistance or escape, as it's called, isn't nearly as scary as bacteria becoming resistant to antibiotics. And this evolutionary pressure is present for any vaccine that doesn't completely block infection. Many vaccines, apparently, including the COVID vaccines, do not completely prevent a virus from multiplying inside someone even though these vaccines do prevent serious illness.

Note: This informative article presents further data that vaccines lead to increased mutation in viruses. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.

A little more than a third of nursing home workers have been getting COVID-19 vaccines when the shots are first offered, U.S. health officials said Monday. The Centers for Disease Control and Prevention gave a national accounting of a problem that's been reported anecdotally – many nursing home workers are not getting the shots. The CDC looked at more than 11,000 nursing homes and skilled nursing facilities that had at least one vaccination clinic between the middle of December and the middle of January. The researchers found that while 78% of residents got at least one shot, only 37.5% of staff members did. Data previously showed that people who work in nursing homes and long-term care facilities get flu vaccines at lower rates than other health-care workers. Surveys suggest that long-term care workers are skeptical the shots work and don't think viruses spread easily from them to the people they care for. The CDC released a second report Monday that offered a larger national look at who has been getting the vaccine. The CDC study found that of the people who got at least one shot between mid-December and mid-January, 63% were women, and 55% were age 50 or older.

Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.

On Jan 13, Dr Yvonne Doyle, the medical director at Public Health England (PHE) issued an alarming statement claiming that Britain had reported the highest number of coronavirus deaths on a single day since the pandemic began. She also alleged that there have now been more deaths in the second wave than the first. Dig a little deeper and the narrative that the second wave is more deadly than the first begins to unravel. According to the Continuous Mortality Investigation (CMI) ... there were 72,900 excess deaths from the start of the pandemic in March to the end of December. Some 60,800 of those occurred in the first wave, but just 12,100 in the second. In a bad winter flu season, around 22,000 excess deaths would be expected. It means that, unlike the first wave, many people included in the coronavirus death figures would have been expected to die of other causes in the past few months. The mortality rate in December 2020 was 1,339.8 deaths per 100,000 males, compared with 1,674.7 in December 2003, and 950.4 deaths per 100,000 females, compared with 1,217.4 in December 2003. The ONS estimates that there were 50,882 more deaths in England in 2020, and 71,110 were due to coronavirus. This means that at least 20,000 people who died from coronavirus last year would have been likely to have died from something else. The figure is likely to be higher because many more people have died from the impact of lockdown.

Note: For more, see this article. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

Youtube recently banned a video. In the video, Dr. Michael Yeadon said half or even almost all of the tests for COVID are false positives. Youtube banned the video within hours. Perhaps what irked the Big Tech was Yeadon's assertion that the panic over the second or third wave of coronavirus may be unfounded. Yeadon, who had worked as Chief Science Officer for pharmaceutical giant Pfizer for 16 years, went on to say that "this pandemic is fundamentally over." Yeadon argues, citing principles of epidemiology, that a "second wave" of COVID is entirely manufactured. Citing the experience with other recent virus outbreaks - the SARS virus in 2003, and MERS in 2012 - he says that the idea of subsequent waves itself is wrong. Instead, what appears like subsequent waves is actually a single wave occurring in different geographical regions at different points in time. "It is actually multiple single waves affecting geographically distinct populations at different times as the disease spreads. Analyzed individually, each area followed a typical single event," he says about MERS. He gave another blow to the establishment, saying that lockdown did not actually help curb the virus spread. Yeadon cites the now-famous example of Sweden. Covid-19 doomsday preacher Neil Fergusson had said Sweden would see 40,000 deaths by May and 100,000 in later months as it did not lock up people in grids. Yet, Sweden's coronavirus toll is 6,000 as of now.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

A great deal of conflicting information has emerged about the immune response that develops in patients who have recovered from Covid-19. The good news is that we are unlikely to be reinfected with Sars-Cov-2 repeatedly until it eventually wipes us all out. Most of the evidence ... shows that the immune response to this is quite typical for an acute viral infection. Initially, the body ramps up high levels of IgG antibodies, but after the infection is cleared, those antibodies drop to a baseline level, which may be below the limit of detection of some serological tests. Most people who recover from Covid-19 have detectable neutralising antibodies months after infection. This suggests that Sars-Cov-2 infection does produce an immune response that is protective, at least for several months. Furthermore, antibodies are not the only important part of the immune system. T-cells are also a key component to the immune response. They come in two flavours: helper T-cells, which coordinate immune responses and facilitate immunological memory, and killer T-cells, which kill infected cells. Previous studies have shown that Sars-Cov-2 infection induces robust T-cell responses. Interestingly, some people who have never had Covid-19 have memory T-cells from prior common-cold coronavirus infections that cross-react with Sars-Cov-2, suggesting that there may be some existing protection in the population. T-cells alone are unlikely to provide complete immune protection, but they are a key contributor to immune memory.

Note: The author of this article, Angela Rasmussen, is a virologist and affiliate of the Georgetown Center for Global Health Science and Security. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

Previous vaccines have taken a decade or more to develop, and more than half of the past 20 years have failed in clinical trials. However, four [COVID-19] vaccine candidates have entered the final phase of clinical trials prior to approval by the Food and Drug Administration. Operation Warp Speed ... organized government agencies and private companies with the goal of developing, manufacturing and distributing hundreds of millions of vaccine doses, with starting doses to be available by early 2021. At the head of the operation is Moncef Slaoui, a Moroccan-born Belgian-American scientist. Operation Warp Speed … has invested in six vaccine candidates (Moderna, Pfizer / BioNTech, Johnson & Johnson, AstraZeneca, Novavax, and Sanofi / GSK) with the hope that at least one ... will prove safe and effective in clinical trials. Four of the six vaccine candidates have already been shown to be safe and effective in the first two test phases, which test whether the vaccinations produce so-called neutralizing antibodies. Serious health problems regularly arise during vaccination attempts. "We know how to distribute vaccines to any location in the US," says Slaoui. "It happens every year for flu and shingles." Tracking systems need to be "incredibly precise" to ensure that patients are each given two doses of the same vaccine and to monitor them for adverse health effects. Operation Warp Speed … has selected medical distributor McKesson and cloud operators Google and Oracle to collect and track vaccine data.

Note: The above article is also available here. Don't miss this excellent article which raises many important questions about this operation. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and vaccines from reliable major media sources.

The Centers for Disease Control and Prevention was created to stop deadly pathogens. But 2020 has been a disaster for the CDC. The agency's response to the worst public health crisis in a century - the coronavirus pandemic - has been marked by technical blunders and botched messaging. The agency has endured false accusations and interference by Trump administration political appointees. Worst of all, the CDC has experienced a loss of institutional credibility at a time when the nation desperately needs to know whom to trust. The stumbles started early in the pandemic, with the botched rollout of test kits suspected of being contaminated at a CDC lab in late January. But the agency's most chronic problem has been the inability to speak directly and persuasively to the American public. That's because it has been muzzled ... by political operatives. White House officials have pressured the CDC to change guidance over the last several months to align the guidelines more closely with the administration's message that the pandemic is under control, federal health officials have said. Those actions include revised CDC guidance on mask-wearing and the reopening of religious institutions and schools. "Every big public health response has two components: the public health emergency and the political emergency," said a CDC epidemiologist who spoke on the condition of anonymity out of fear of retaliation. "I never would have expected the level of political interference we're seeing now. It's so sad."

Note: For more along these lines, see concise summaries of deeply revealing news articles on government corruption and the coronavirus from reliable major media sources.

AstraZeneca revealed details of its large coronavirus vaccine trials on Saturday, the third in a wave of rare disclosures by drug companies under pressure to be more transparent about how they are testing products that are the world's best hope for ending the pandemic. Polls are finding Americans increasingly wary of accepting a coronavirus vaccine. Experts have been particularly concerned about AstraZeneca's vaccine trials, which began in April in Britain, because of the company's refusal to provide details about serious neurological illnesses in two participants, both women, who received its experimental vaccine in Britain. Those cases spurred the company to halt its trials twice, the second time earlier this month. The studies have resumed in Britain, Brazil, India and South Africa, but are still on pause in the U.S. About 18,000 people worldwide have received AstraZeneca's vaccine so far. The company has released few details about the two cases of serious illness in its trial. The first participant received one dose of the vaccine before developing inflammation of the spinal cord, known as transverse myelitis. The condition can cause weakness in the arms and legs, paralysis, pain and bowel and bladder problems. The company said it had not confirmed a diagnosis in the second case, a participant who got sick after the second dose of the vaccine. A person familiar with the situation who spoke with The Times on the condition of anonymity said the participant's illness had been pinpointed as transverse myelitis.

Note: Why won't the company let the two who became seriously ill speak to the media? And why initially did they hide the fact that the illnesses were serious? And why are top vaccine executives now dumping their shares of stocks? For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and Big Pharma corruption from reliable major media sources.

Last August, NPR profiled a Harvard-led experiment to help low-income families find housing in wealthier neighborhoods. Every quoted expert is connected to the Bill & Melinda Gates Foundation, which helps fund the project. NPR itself receives funding from Gates. The story ... is one of hundreds NPR has reported about the Gates Foundation or the work it funds, including myriad favorable pieces written from the perspective of Gates or its grantees. And that speaks to a larger trend - and ethical issue - with billionaire philanthropists’ bankrolling the news. As philanthropists increasingly fill in the funding gaps at news organizations ... an underexamined worry is how this will affect the ways newsrooms report on their benefactors. Nowhere does this concern loom larger than with the Gates Foundation. During the pandemic, news outlets have widely looked to Bill Gates as a public health expert on covid - even though Gates has no medical training and is not a public official. PolitiFact and USA Today (run by the Poynter Institute and Gannett, respectively - both of which have received funds from the Gates Foundation) have even used their fact-checking platforms to defend Gates from “false conspiracy theories” and “misinformation,” like the idea that the foundation has financial investments in companies developing covid vaccines and therapies. In fact, the foundation’s website and most recent tax forms clearly show investments in such companies, including Gilead and CureVac.

Note: Watch an excellent 15-minute presentation by courageous journalist Ben Swann on the agenda of facebook fact checkers. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and media manipulation from reliable major media sources.

The COVID-19 pandemic is having a significant impact on Americans' mental health, according to a new survey out Thursday from the U.S. Centers for Disease Control and Prevention. It found elevated levels of symptoms of anxiety and depressive disorders, substance use and suicidal ideation among U.S. adults, and identified populations at increased risk, including young people, racial and ethnic minorities, essential workers and caregivers of adults. More than 40% of respondents who completed surveys during June reported an adverse mental or behavioral health condition, and 11% reported having seriously considered suicide in the 30 days prior. The data's greatest value, experts say, is the spotlight it shines on vulnerable populations. "It is showing that this breakdown in our society, the breakdown of the safety net, the breakdown of economic security is taking a massive toll," said Anna Mueller, a suicide researcher and professor of sociology at the Indiana University Bloomington. "These breakdowns really show how crucial economic stability and economic security are to an individual's well being. Because the people who are more vulnerable in terms of their socioeconomic status, people who are being put in harm's way, those are the people who are suffering the most." The survey found 75% of respondents 18-24 reported at least one adverse mental or behavioral health symptom and serious suicidal ideation among this group was 25%.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and health from reliable major media sources.

Scientists have devised a way to use the antibody-rich blood plasma of COVID-19 survivors for an upper-arm injection that they say could inoculate people against the virus for months. Using technology that's been proven effective in preventing other diseases such as hepatitis A, the injections would be administered to high-risk healthcare workers, nursing home patients, or even at public drive-through sites. But the idea exists only on paper. Federal officials have twice rejected requests to discuss the proposal, and pharmaceutical companies — even acknowledging the likely efficacy of the plan — have declined to design or manufacture the shots. The antibodies in plasma can be concentrated and delivered to patients through a type of drug called immune globulin, or Ig, which can be given through either an IV drip or a shot. Yet for the coronavirus, manufacturers are only developing an intravenous solution of Ig. Intravenous plasma products are traditionally the main economic driver for the industry. The money-making antibodies are also far more diluted in intravenous drugs than in injectable ones, which boosts profit margins. “They charge a fortune off of intravenous drugs in the hospital. They don't want to devote the manufacturing plant to something that won't make oodles of money,” said one infectious disease expert. Researchers also said industry executives have little incentive to produce the immunity shots for the coronavirus, given the possibility that a longer-lasting vaccine could replace it within a year.

Note: For more along these lines, see concise summaries of deeply revealing news articles on big Pharma corruption and the coronavirus from reliable major media sources.

Sweden's state epidemiologist Anders Tegnell has hit back at the World Health Organization after it included Sweden in a group of countries facing "a very significance resurgence" of coronavirus infections. Mr Tegnell, who has in recent months become one of the world's most high profile and divisive epidemiologists, said: "That is, unfortunately, a total misinterpretation of the data." "It's very unfortunate that people lump Sweden together with countries that earlier have had no problem at all and are now apparently at the start of their epidemic," he told Sweden's state broadcaster SVT. Hans Kluge, the WHO's Regional Director for Europe, on Thursday named Sweden in a list of eleven problem countries ... which are facing "accelerated transmission" of infection. Sweden has this month seen the daily number of confirmed cases more than triple from 60 on June 1st to 207 on Thursday. But Mr Tegnell argued that this has to do with increased testing rather than a resurgence in infection. "This is growing because we recently started offering tests to everyone with symptoms," he told Sweden's TT newswire. "We are doing twice as many tests as we were a few weeks ago. But the growth we are seeing is in mild cases, not hospital admissions." Mr Tegnell has drawn both admiration and criticism internationally for leading a coronavirus strategy that left schools for 14-16 year olds open throughout the pandemic, as well as bars, restaurants, gyms, and much else, relying instead on the public's willingness to follow social distancing guidelines.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

The authors of a British-Norwegian vaccine study - accepted by the Quarterly Review of Biophysics - claim that the coronavirus's spike protein contains sequences that appear to be artificially inserted. In their paper, the Norwegian scientist Birger Srensen and British oncologist Angus Dalgleish claim to have identified "inserted sections placed on the SARS-CoV-2 spike surface" that explains how the virus interacts with cells in the human body. The reports authors also claim the lack of mutation in the virus since its discovery, suggests it was already fully adapted to humans. Srensen ... claimed that China and the United States have collaborated for many years on coronavirus research through "gain of function" studies, in which the pathogenicity or transmissibility of potential pandemic pathogens can be enhanced.

Note: One day after being published, this article was greatly changed and given the new title "Controversial Coronavirus Lab Origin Claims Dismissed By Experts." A paragraph at the top of the article now states, "This article has been substantially updated to reflect criticism of the published study, along with the general scientific consensus on Covid-19." Since when is an article changed because is it criticized or not in line with scientific consensus? For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from major media sources.

The World Health Organization is recommending healthy people, including those who don’t exhibit COVID-19 symptoms, only wear masks when taking care of someone infected with the contagion, a sharp contrast from the advice given by American public health officials who recommend everyone wear a mask in public. “If you do not have any [respiratory] symptoms such as fever, cough or runny nose, you do not need to wear a mask,” Dr. April Baller, a public health specialist for the WHO, says. “Masks should only be used by health care workers, caretakers or by people who are sick with symptoms of fever and cough.” The recommendation differs from the Centers for Disease Control and Prevention (CDC), which urges individuals to wear a mask or face covering in public settings, regardless of infection, to limit the spread of the virus. “We now know from recent studies that a significant portion of individuals with coronavirus lack symptoms (‘asymptomatic’) and that even those who eventually develop symptoms (‘pre-symptomatic’) can transmit the virus to others before showing symptoms,” the CDC mask guidance says. “In light of this new evidence, CDC recommends wearing cloth face coverings in public settings where other social distancing measures are difficult to maintain.” Baller noted that masks can give people a “false feeling of protection” and noted that sick individuals should wear one to prevent transmitting the virus to others.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.